Medical Scientist Training Program

医学科学家培训计划

• 批准号: 10158495
• 负责人: DIANNA M MILEWICZ
• 金额: $ 22.56万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-01 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10158495
• 关键词: Medical; Scientist; Training Programs

PROJECT SUMMARY The mission of our multi-institutional MD/PhD Program, comprised of the University of Texas Health Science Center at Houston McGovern Medical School (UTHealth) and MD Anderson Cancer Center (MDACC), and in conjunction with the University of Puerto Rico Medical Sciences Campus School of Medicine (UPR), is to pursue novel training of a diverse group of intellectually gifted students for careers as physician-scientists focused on disease-oriented research and bridging the knowledge gap between medicine and basic science. The MD/PhD program has been continuously funded since 1982 and has graduated 105 students, including a current Director of our program. To expand diversity in our physician-scientist trainees, we have partnered with the UPR, leveraging a NIH-funded MDACC/UPR U54 Partnership for Excellence in Cancer Research award to integrate into our MD/PhD Program those talented UPR medical students who want to pursue research careers, and approximately 30% of our program is underrepresented minorities (URM). Applications to our program from students from across the country have doubled over the past 10 years, allowing us to matriculate a group of highly qualified students (51 students currently in the program). To prepare physician-scientists to pursue disease-oriented research, a novel educational sequence was established to integrate the medical and graduate school. Although students begin to fulfill graduate school requirements from the very beginning of the program, they complete the clinical specialty rotations before pursuing dissertation research. Students can select from 9 graduate training programs in biomedical sciences. Support for this educational sequence is provided by the fact that, in the past 10 years, attrition from the program has been 4% and the time to completion is 7.8 years. The quality of students and the program are exemplified by strong publication records and excellent residency matches. A major element to enhance training is the Topics in Molecular Medicine course, which provides vertical integration and community for the students, exposure to the breadth and depth of research at the institutions, and insights into career development and leadership. Based on graduates over the past 15 years, the majority of our post-training trainees are in academic positions or industry (76%; n = 38; 28 academic positions + 1 in industry). MSTP support is requested for a total of 6 matriculating students per year by year 3 of the training grant period, to expand the number of students in this unique and diverse training program.

项目摘要 我们的多机构MD/博士课程的使命，包括得克萨斯大学健康科学 休斯顿麦戈文医学院（UTHealth）和MD安德森癌症中心（MDACC）的中心，以及 与波多黎各大学医学院（UPR）合作， 对不同类型的智力天才学生进行新的培训，使他们成为医生和科学家 重点是以疾病为导向的研究和弥合医学与基础科学之间的知识差距。 MD/PhD课程自1982年以来一直得到资助，已有105名学生毕业，其中包括一名 现任我们项目的负责人为了扩大我们的医生科学家学员的多样性，我们与 UPR利用NIH资助的MDACC/UPR U 54癌症研究卓越合作奖， 将那些想要从事研究的有才华的UPR医学生融入我们的MD/PhD课程 我们的计划中约有30%是代表性不足的少数民族（URM）。应用到我们的 来自全国各地的学生的计划在过去10年中翻了一番，使我们能够入学 一群高素质的学生（目前有51名学生在该计划）。为了让医生科学家做好准备 追求以疾病为导向的研究，建立了一个新的教育序列，将医疗和 研究生院虽然学生从一开始就开始达到研究生院的要求， 计划，他们完成临床专业旋转之前，追求论文研究。学生可以 从生物医学科学的9个研究生培训计划中选择。支持这一教育序列是 事实上，在过去的10年里，该计划的减员率为4%， 完成时间为7.8年。学生的质量和程序是由强大的出版记录证明 和出色的住院医师比赛加强培训的一个主要因素是分子医学主题 课程，为学生提供垂直整合和社区，接触的广度和深度 在机构的研究，以及对职业发展和领导力的见解。基于毕业生超过 过去15年，我们的培训后学员大多数在学术职位或行业（76%; n = 38; 28个学术职位+ 1个工业职位）。MSTP的支持是要求共6个录取学生， 每年3年的培训补助金期间，扩大学生人数在这一独特和多样化的培训 程序.